April 15 - 16, 2019
National Institutes of Health Masur Auditorium
Abstract submission deadline: Wednesday, April 10
Advance registration deadline: Tuesday, April 16
Held for the first time in 2018, the Cancer, Autoimmunity, and Immunology Conference was created to delve into 1) understanding the biology of immune-related adverse events that have occurred in cancer patients treated with immunotherapies and how that might inform the study of autoimmune disease; and 2) defining the potential for the study of autoimmune disease to lead to greater understanding of the treatment and management of immune-related adverse events during and following cancer therapies.
This year, the NIH-AACR Cancer, Autoimmunity, and Immunology Conference will feature sessions focusing on gastrointestinal, neurological, ocular, and skin toxicities; and the use of pre-clinical models and meta-analyses for interrogating immune-related adverse events. There will be Keynote Presentations from Arlene H. Sharpe, MD, PhD; Elizabeth M. Jaffee, MD; and Jennifer A. Wargo, MD, MMSc.
Continuing Medical Education Activity
AMA PRA Category 1 CreditsTM available